000 01507 a2200397 4500
005 20250515004834.0
264 0 _c20060828
008 200608s 0 0 eng d
022 _a1071-412X
024 7 _a10.1128/CDLI.12.11.1340-1342.2005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaraca, Kemal
245 0 0 _aImmunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats.
_h[electronic resource]
260 _bClinical and diagnostic laboratory immunology
_cNov 2005
300 _a1340-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies, Viral
_xbiosynthesis
650 0 4 _aCat Diseases
_ximmunology
650 0 4 _aCats
650 0 4 _aFowlpox virus
_ximmunology
650 0 4 _aHemagglutination Inhibition Tests
650 0 4 _aHemagglutinin Glycoproteins, Influenza Virus
_xbiosynthesis
650 0 4 _aHumans
650 0 4 _aInfluenza Vaccines
_xadministration & dosage
650 0 4 _aInfluenza, Human
_xprevention & control
650 0 4 _aOrganisms, Genetically Modified
_ximmunology
700 1 _aSwayne, David E
700 1 _aGrosenbaugh, Deborah
700 1 _aBublot, Michel
700 1 _aRobles, Amy
700 1 _aSpackman, Erica
700 1 _aNordgren, Robert
773 0 _tClinical and diagnostic laboratory immunology
_gvol. 12
_gno. 11
_gp. 1340-2
856 4 0 _uhttps://doi.org/10.1128/CDLI.12.11.1340-1342.2005
_zAvailable from publisher's website
999 _c15900966
_d15900966